WO2013016984A1 - Aortic aneurysm dissection stent system and preparation method thereof - Google Patents

Aortic aneurysm dissection stent system and preparation method thereof Download PDF

Info

Publication number
WO2013016984A1
WO2013016984A1 PCT/CN2012/077245 CN2012077245W WO2013016984A1 WO 2013016984 A1 WO2013016984 A1 WO 2013016984A1 CN 2012077245 W CN2012077245 W CN 2012077245W WO 2013016984 A1 WO2013016984 A1 WO 2013016984A1
Authority
WO
WIPO (PCT)
Prior art keywords
stent
wire
occlusion device
aortic aneurysm
delivery
Prior art date
Application number
PCT/CN2012/077245
Other languages
French (fr)
Chinese (zh)
Inventor
刘刚
曾筝
成正辉
黄连军
Original Assignee
北京华医圣杰科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 北京华医圣杰科技有限公司 filed Critical 北京华医圣杰科技有限公司
Publication of WO2013016984A1 publication Critical patent/WO2013016984A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • A61B17/12118Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00526Methods of manufacturing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/823Stents, different from stent-grafts, adapted to cover an aneurysm

Definitions

  • the invention relates to a novel medical device, in particular to a sandwich stent system for implanting aortic aneurysm and a preparation method thereof.
  • Aortic dissection aneurysm is the most dangerous type of aortic aneurysm.
  • the high blood flow of the artery enters the middle layer of the artery wall from the tear of the aortic intima, separating the inner and outer layers and expanding along the middle layer to form a "mezzanine. "A structure of an aneurysm.
  • the high pressure blood flow inwardly compresses the intima to narrow the obstruction of the aorta, causing the weak aortic wall to bulge outwards, which can cause rupture.
  • the degeneration of the middle layer and the decrease of tissue adhesion are also important causes of aortic dissection.
  • aortic aneurysm can be divided into several types.
  • Stanford classification can be divided into type A and type B;
  • Debakey classification can be divided into type I, type II and type III.
  • Stanford type A is equivalent to Debakey type I and type II, accounting for approximately 65-70% of dissecting aneurysms;
  • Stanford type B is equivalent to Debakey type III, accounting for approximately 30-35%.
  • Common aneurysm dissection is often due to rupture of blood loss, pericardial tamponade, arrhythmia or renal failure.
  • the aortic dissection aneurysm is extremely dangerous.
  • the 24-hour survival rate after dissection of the aneurysm is only 40%, the 1-week survival rate is 25%, and the 3-month survival rate is only 10%.
  • Argentine vascular surgeon Parodi pioneered a minimally invasive treatment of aneurysms, endovascular exclusion. Endovascular exclusion is performed in the lumen of the artery. It does not require a thoracotomy. It only cuts a small opening in the groin.
  • a catheter containing a suitable size of artificial blood vessels is placed from the femoral artery. After introduction, after reaching the aortic lesion, the artificial blood vessel is released from the catheter, and the artificial blood vessel with the Nitinol stent is automatically opened, firmly fixed to the inner wall of the aorta, and the gap is completely closed. The residual resting blood will gradually become thrombotic and eventually become scarred.
  • Aortic stenting for the treatment of aortic dissection and dissection aneurysms is a recent advancement in interventions.
  • the treatment goal of the aortic dissection is to isolate the proximal aortic rupture, thereby opening the true cavity, sealing the false lumen, and forming a thrombus in the false lumen.
  • it will cause the reverse tear of the interlayer, causing the dissection of the aortic arch or even the ascending aorta. Difficult complications. Placing the stent in the relatively fragile dissection of the aortic wall and placement on the atherosclerotic aneurysm vessel wall may result in completely different results.
  • the stent-targeting zone requires only a small portion of the relatively normal vessel wall; however, the aortic dissection requires both a better orientation and no excessive damage to the vessel wall.
  • the stent also requires a certain degree of compliance, which ensures that the true cavity can be gradually expanded, and the false lumen is continuously compressed, so as to ensure the success of the treatment.
  • the present invention provides a system for providing an aortic aneurysm sandwich stent and a method for preparing the same.
  • the aortic aneurysm stent system includes a separate stent and an occlusion device, and further includes a stent delivery system and a occlusion device delivery system, the stent is woven from the stent braided wire, and the release state is the same as the main a cylindrical structure in which the inner wall of the aneurysm is fitted, the occlusion device comprises a occlusion device net body, and the net body of the occlusion device is woven by a tying device, and is sealed in a released state.
  • the occlusion surface of the aortic aneurysm wall opening comprising a stent delivery catheter and a distal end thereof for assembling and delivering the stent, and a stent delivery guide for transporting the vessel through the stent delivery catheter to the aortic aneurysm
  • the occlusion device delivery system includes a occlusion device delivery catheter having a locating marker at the distal end and a distal end thereof for fixing and releasing the occlusion device, and a delivery catheter from the occlusion device to the aortic aneurysm
  • a occlusion device at the opening of the vessel wall delivers a guidewire.
  • the stent has contractility, and has a mesh-like cylindrical shape in a released state, and is contracted and fixed on the stent delivery guide wire in a delivery state and transported from the lumen of the stent delivery catheter to the aortic aneurysm.
  • a bracket indicator is disposed on the two ends of the length direction of the bracket, and the bracket is made of a platinum alloy, a nickel-titanium alloy or a gold alloy, and is fixedly connected to the bracket braided wire by welding, and the bracket conveys a guide wire.
  • a stent delivery guidewire indicator corresponding to the stent indicator is fixed on the upper surface.
  • the stent delivery guide wire is made of a biopolymer material having an outer diameter of 2.37-2.41 mm, an inner diameter of 1.02-1.06 mm, a guide wire of 0.036"-0.040" in the middle, and a length of 900-1000 mm.
  • the stent delivery catheter is made of a biopolymer material having an outer diameter of 0.60 mm to 1.80 mm and an inner diameter of 0.35 mm to 1.20 mm.
  • the bracket is made of nickel-titanium gold wire, titanium wire, tungsten wire, NITI wire, silk wire, composite wire of stainless steel wire and platinum, one or several kinds of bracket braided wires of NITI and gold composite wire.
  • the stent braided wire has a diameter of 0.020 mm to 0.060mm, the number is one, the outer diameter of the bracket after full release is 6mm to 30mm, and the length is 10mm to 50mm.
  • the occlusion device has a layered double-disc structure with a shape memory function in a state in which the occlusion device is in a released state, and the outer surface of the occlusion surface is sewn with a medical refractory film.
  • the occlusion device comprises a distal end indication of the occlusion device on the sealing surface of the occlusion device, a proximal end indication of the occlusion device on the opposite side of the double disc structure, and a connection member connected to the proximal end indication of the occlusion device,
  • the guiding device conveying guide wire comprises a distal plug head, a middle shaft and a joint from the distal end, and an outer tube on the outer side, wherein the outer tube is made of biomedical polymer material, and the distal end of the distal plug is connected with the connecting piece.
  • the tube is mated in the inner cavity, and the other end is connected to the central shaft by welding.
  • the central shaft is made of stainless steel or nickel-titanium alloy
  • the outer tube has an inner diameter of 1.0 mm to 2.0 mm, an outer diameter of 1.5 mm to 2.5 mm, a length of 1000 mm to 1500 mm, and a proximal end of the outer tube is bonded to a handle.
  • the outer diameter of the shaft is 0.25 mm to 0.8 mm
  • the length is 1200 mm to 1800 mm
  • the distal end of the central shaft has a tapered transition section.
  • the proximal indicator of the distal marking and blocking device of the occlusion device is made of platinum alloy, nickel-titanium alloy, stainless steel or gold alloy, and the distal end of the tying device and the occlusion device of the occlusion device and the occlusion device The proximal indicator is fixedly connected by soldering.
  • the occlusion device delivery catheter is made of a biopolymer material having an inner diameter of 2 mm to 5 mm and an outer diameter of 2.5 mm to 6 mm, and the distal end is provided with a distal end of the occlusion device delivery catheter.
  • the occlusion device net body adopts one or more kinds of nickel-titanium gold wire, titanium wire, tungsten wire, NiTi wire, filature wire, composite wire of stainless steel wire and bismuth, and composite wire of NiTi and gold.
  • the woven wire of the device is woven by a diameter of 0.05 mm to 0.1 mm, and the number is 8 to 288.
  • the diameter of the double disk after the net body of the occlusion device is completely released is 2 mm to 10 mm.
  • the method for preparing the aortic aneurysm sandwich stent system comprises the following steps: A. stent weaving and sizing, the stent braided wire is manually woven on the stent woven mold, and the stent is placed on both ends of the stent during the weaving process. The woven finished stent is heat treated and shaped together with the mold. After the thermoforming, the bracket is removed from the mold, and the bracket and the bracket indicator are welded by welding; B. The stent is conveyed by a guide wire, and the plastic tube is extruded on the tube extruder. After assembling the plastic pipe, the plastic pipe is fused on the rheometer, and the joint is injected on the injection molding machine after the pipe is completed; C.
  • the mesh body of the woven plugging device is woven, and the braiding wire of the plugging device is woven on the knitting machine to seal The braided wire of the plugging device is evenly distributed; D.
  • the plugging device is prepared, the net body of the plugging device is mounted on the forming device of the plugging device, and then the mesh body of the plugging device after the molding is heat-treated and shaped, and the mold is sealed after thermoforming.
  • the plugging device is taken out from the net body, and the two ends of the netting device of the plugging device are equipped with a distal end marking device and a proximal end indicating device for the blocking device, and the closing device is shown at the proximal end.
  • the connecting piece is installed inside, and the netting device of the plugging device and the distal end of the plugging device and the proximal end of the plugging device are welded by welding, and the meshing body of the plugging device after welding is sealed with a choke film;
  • the shaft is made by the plugging device.
  • the alloy wire is placed on the stainless steel ruler to measure the length.
  • the alloy wire is cut with the diagonal pliers.
  • One end of the middle shaft is ground on the cylindrical grinding machine, and the plug and the seal are sealed.
  • the blocking device conveying guide wire is connected by welding.
  • the heat treatment is performed by a vacuum heat treatment furnace under the condition of 50 CTC for 30 minutes; the welding is performed by a laser welding machine or a TIG welding method.
  • the aortic aneurysm stent system utilizes a separate stent and a occlusion device, and the guide wire is connected to the occlusion device through the occlusion device, and is pushed to the lesion through the occlusion device delivery catheter, and released.
  • the opening of the vessel wall is blocked, the aortic artery and the dissection are isolated, and the hemodynamics of the aortic aneurysm is changed.
  • the stent is pushed to the lesion by the stent delivery system, and the inner wall of the vessel is supported after being released.
  • the blocking device ensures the firmness of the occlusion device and does not shift under the impact of blood flow, which makes the operation safer and more effective.
  • the minimally invasive surgical puncture point and delivery The diameter of the sheath is greatly reduced to prevent excessive arterial damage.
  • the stent delivery guide wire of the invention has good flexibility and pushing performance, is soft at the distal end, can be freely transported in complicated blood vessels and does not damage the inner wall of the blood vessel; the proximal end is hard and can provide good push performance; the flexibility of the stent delivery catheter is flexible Well, it can freely transport in complex blood vessels without damaging the inner wall of the blood vessel; the occlusion device delivers a flexible catheter and a good folding resistance, and can be freely transported in complex blood vessels.
  • a vacuum heat treatment process is adopted during the molding process of the stent and the occlusion device to ensure the shape memory property and elasticity of the occlusion device, and the material is not oxidized and deformed by the internal stress of the material;
  • the stent delivery catheter and the occlusion device The delivery catheter tube body is reinforced with a steel mesh and a spring to ensure the tensile strength of the tube body and has good bending resistance, and can ensure bending and damage of the endovascular membrane in the curved blood vessel.
  • the plugging device network tube and plug head adopt laser welding or TIG welding process to ensure the welding strength is firm.
  • Figure 1 is a schematic view of a stent of the present invention
  • Figure 2 is a schematic view showing the guide wire of the stent and the stent of the present invention
  • Figure 3 is a structural view of the conveying device of the patent holder of the present invention.
  • Figure 4 is a schematic view of the occlusion device of the present invention.
  • Figure 5 is a schematic view showing the assembly of the guide wire of the occlusion device of the present invention.
  • Figure 6 is a structural view of the conveying device of the patented occlusion device of the present invention.
  • Figure 7 is a schematic view of the aortic aneurysm sandwich device before placement
  • FIG. 8 Schematic diagram of the delivery process of the aortic aneurysm sandwich device
  • Figure 9 is a schematic view of the aortic aneurysm sandwich device after placement
  • FIG. 10 Schematic diagram of the aortic aneurysm stent graft delivery process
  • FIG. 11 Schematic diagram of the placement of the aortic aneurysm sandwich stent
  • FIG. 12 is a schematic view showing a braided mesh tube of an embodiment of the aortic aneurysm sandwich stent system
  • Figure 13 is a structural view of a molding die of an occlusion device of the embodiment of the aortic aneurysm sandwich stent system, The numbers in the drawings are listed below:
  • the aortic aneurysm stent system of the present embodiment comprises a stent and a occlusion device, and respectively comprises a stent delivery system and a delivery system of the occlusion device, and the specific structure is as follows:
  • the bracket 1 is a mesh structure using a superelastic NITI alloy wire, and of course, other braided wires capable of forming a radial contraction may be used, including a bracket proximal end indicator 2a and a bracket distal end labeling. 2b.
  • the stent delivery guide wire 4 has three indicators, that is, the stent delivery guide wire distal indicator 3a, the stent delivery guide wire positioning indicator 3b, and the stent delivery guide wire proximal indicator 3c.
  • the stent 1 is assembled on the stent delivery guide wire 4 and passed through the lumen of the stent delivery catheter 5.
  • the distal end marker 2b of the stent coincides with the distal marker 3a of the stent delivery guidewire, and the proximal marker 2a of the stent coincides with the proximal marker 3c of the stent delivery guidewire.
  • the occlusion device of the present embodiment is also made of a superelastic NITI alloy wire or other woven wire having a memory function, and includes a occlusion device net body 6 and a distal end indication plate 7 of the occlusion device.
  • the closure device has a proximal indicator 8 and a connector 9.
  • the occlusion device delivery guide 18 includes a distal plug 10, a central shaft 11, an outer tube 12 and a joint 13.
  • the delivery guide wire distal end plug 10 and the occlusion device connector 9 are cooperatively connected in the inner cavity of the delivery guide wire outer tube 12, and the delivery guide wire middle shaft 11 and the distal ferrule 10 are connected by welding.
  • the distal plug head 10 is loosened with the occlusion device connector 9, and the occlusion device mesh body 6 can be detached from the delivery guide wire.
  • the occlusion device delivery guide wire 18 with the occlusion device mesh body 6 is passed along the lumen of the occlusion device delivery catheter 14, and the occlusion device is pushed to transport the guide wire 18 until it is observed under DSA development.
  • the occlusion device distal indicator 7 coincides with the occlusion device delivery catheter distal indicator 15.
  • the occlusion device delivery catheter 14 is withdrawn, and the occlusion device mesh body 6 is released from the delivery catheter, and the superelastic NITI alloy wire is automatically expanded and expanded into its original shape.
  • the delivery process of the occlusion device mesh body using the occlusion device to deliver the visibility of the catheter distal end 15 under X-rays, the occlusion device delivery catheter 14 along the aorta 16 Pushed to the aortic aneurysm 17 at a predetermined location.
  • the occlusion device delivery guide wire 18 with the occlusion device mesh body 6 is fed into the delivery catheter 14, and the relative position of the delivery guide wire guide shaft 13 and the delivery guide wire outer tube 12 is tightened by tightening the occlusion device delivery guide wire connector 13. . Feed the guide wire 18 forward until The occlusion device distal indicator 7 and the occlusion device delivery catheter distal indicator 15 coincide.
  • the delivery catheter 14 is withdrawn, and the occlusion device mesh 6 begins to be released.
  • the visibility of the distal indication 7 of the occlusion device and the proximal indicator 8 of the occlusion device under X-rays adjust the corresponding position, so that the two devices of the occlusion device net body 6 are located on both sides of the inner membrane of the vascular sandwich.
  • the occlusion device is released to transport the guide wire connector 13, the outer guide tube 12 of the guide wire is retracted, the mesh body 6 of the occlusion device is released, and the guide wire 18 is withdrawn from the occlusion device.
  • the occlusion device delivers the catheter 14.
  • the occlusion device net body 6 is attached to the inner membrane of the vascular sandwich, and the mesh body blocks the opening of the vascular sandwich layer.
  • the stent is transported, and the stent 1 is loaded into the stent delivery catheter 5, and the distal guide 3a of the guide wire is transported through the stent, the positioning indicator 3b, the proximal indicator 3c and the distal end of the stent are provided.
  • the visibility of the indicator 2b and the stent proximal indicator 2a under X-rays conveys the stent 1 to a predetermined position. Keeping the position of the stent delivery guide wire 4 unchanged, the stent delivery catheter 5 is withdrawn, and the stent 1 is then released. After the stent 1 is completely released, the stent delivery guide wire 4 and the stent delivery catheter 5 are withdrawn. 1 Attached to the inner wall of the blood vessel as shown in Fig. 11, supporting the blood vessel of the aorta 16 and the occlusion device.
  • the specific steps of the aortic dissection stent system of the present embodiment are as follows: 1. When the clinically diagnosed patient is an active tumor dissection patient, the patient is routinely observed before surgery; 2. The patient is subjected to femoral artery puncture, and the conventional aneurysm is found to be aortic aneurysm lesion. After the position, the occlusion device delivery catheter 14 is sent to the lesion portion of the aortic aneurysm 17 through the occlusion device delivery guide wire 18; 3. The occlusion device is used to transport the guide wire 18, and the occlusion device mesh body 6 is inserted into the occlusion device.
  • the occlusion device In the device delivery catheter 14, under the X-ray monitoring, the occlusion device is pushed forward to convey the guide wire 18 until the distal indication ⁇ of the occlusion device coincides with the distal indication 15 of the occlusion device delivery catheter; 4. The delivery device is transported by the occlusion device The visibility of the distal end of the catheter 15 under X-ray confirms that the occlusion device delivery catheter 14 and the distal end of the occlusion device delivery guide wire 18 have passed through the active tumor sandwich opening and into the vascular sandwich; 5.
  • the guide wire 18 retracts the occlusion device delivery catheter 14 at which time the occlusion device mesh body 6 begins to release and expand, and the visibility of the distal and distal ends of the occlusion device 8 and 7 under X-rays is Whether the two plates of the netting device 6 of the blocking device are located on both sides of the inner membrane of the aortic aneurysm 17 and block the opening of the sandwich; if the position is appropriate, the release process of the netting device 6 is completed, and if the position is not suitable, the plate is passed.
  • the occlusion device transports the guide wire 18 to re-integrate the occlusion device net body 6 into the occlusion device delivery catheter 14 so that the distal end of the two components are coincident; the position of the occlusion device delivery catheter 14 is re-adjusted under X-ray monitoring, and the retracement is retracted.
  • the occlusion device delivery catheter 14 releases the occlusion device mesh body 6, until the position of the occlusion device mesh body 6 is just reached the preset position under the DSA development; 6.
  • the traverse delivery guide wire outer tube 12 is such that the occlusion device net body 6 is disengaged from the delivery guide wire shaft 11 and the retort occlusion device transports the guide wire 18; 7.
  • the occlusion device delivery catheter 14 is withdrawn from the body; 8.
  • the stent delivery catheter 5 containing the stent 1 is delivered to the lesion portion of the aortic aneurysm 17 via the stent delivery guide wire 4; IX.
  • the distal and distal end marker 3a is guided through the stent delivery guide wire 3c and 3b illustrates a suitable bit in the position marked visibility under X-ray confirmed the stent delivery system; ten fixed guide wire stent delivery 4, 5 to a stent delivery catheter pullback this time begins to release the stent 1 expanded.
  • the stent 1 is located at the opening of the aortic aneurysm 17 by the visibility of the distal end markers 2b, 2a under the X-ray; ⁇ 1, the stent is transported to the guidewire 4, and the blood patency of the site is observed by contrast technique. Thereafter, the stent delivery catheter 5 is withdrawn from the body.
  • the stent delivery guide wire is made
  • Bracket weaving and sizing Hand-knit the bracket on the bracket woven mold with a diameter of 0.14mm NITI alloy wire. During the weaving process, a platinum-iridium alloy wire-wound indicator is placed on both ends of the bracket; The mold was placed in a ZSK2-12-6 vacuum heat treatment furnace manufactured by Wuhan Industrial Electric Furnace Plant for heat treatment and set at 500 °C for 30 minutes. After thermoforming, the bracket was removed from the mold, and the bracket and the indicator were placed. It is welded by LCT-W1 laser welding machine or TIG welding method manufactured by Beijing Ze Optoelectronic Technology Co., Ltd.
  • Braided mesh body The mesh body shown in Figure 12 was woven on the HTBZ-40 braiding machine manufactured by Shenzhen Huitai Medical Instrument Co., Ltd. with 72 pieces of 0.05mm NITI alloy wire. The NITI wire was evenly distributed on the mesh body.
  • the mesh body is mounted with the clogging device forming mold as shown in Fig. 13; then the woven mesh body after the molding is placed in ZSK1-12-6 manufactured by Wuhan Industrial Electric Furnace General Factory In the vacuum heat treatment furnace, the heat treatment is set, and the temperature is kept for 30 minutes under the condition of 50CTC; after the thermoforming, the mold is taken out from the net body, the ends of the net body are marked with a mark, and the proximal end of the display is equipped with a connecting piece, and the net body is attached.
  • the indicator can be welded by LCT-W1 laser welding machine or TIG welding method manufactured by Beijing Ze Optoelectronic Technology Co., Ltd., and the sealing device after welding can be used to make a complete blocking device.
  • the occlusion device conveys the guide wire to the middle shaft: After cutting the NITI alloy wire with a diameter of 0.65mm according to the design requirements of the drawings, one end of the middle shaft is ground into a TG12X4 cylindrical grinding machine manufactured by ROYAL MASTER GEINDERS.INC in the United States. In accordance with the shape of the design requirements, the stainless steel bolt head and the guide wire purchased according to the design requirements of the drawings are connected by TIG welding method, that is, the shaft of the guide wire for guiding the conveying device is completed.
  • TIG welding method that is, the shaft of the guide wire for guiding the conveying device is completed.
  • the stent has a diameter of 10 mm and a length of 30 mm;
  • the stent delivery catheter has an inner diameter of 2.48 mm, and an outer diameter. 2.97mm;
  • the inner diameter of the stent delivery guide wire is 1.63mm, the outer diameter is 2.39mm, and the middle can pass the guide wire of 0.038";
  • the diameter of the disk surface of the sealing device is 6mm, the axis of the delivery guide wire is 0.65mm, and the inner diameter of the delivery catheter is 1.8mm.
  • the guide wire is first fed, and the occlusion device delivery catheter is pushed to the preset position by the guiding action of the guide wire;
  • the distal indicator determines whether the position of the catheter is correct, withdraws the guide wire, loads the occlusion device into the delivery catheter through the loader, and transports the delivery guide wire forward until the distal end of the occlusion device is observed under DSA development technology.
  • the indicator is coincident with the distal indicator of the delivery catheter; the fixed occlusion device delivers the guide wire, and the delivery catheter is withdrawn.
  • the occlusion device begins to release the expansion, and the indications at the ends of the occlusion device are visible under X-rays.
  • the two plates of the occlusion device are located on both sides of the intima of the aneurysm; if the position is appropriate, the release process of the occlusion device is completed, and if the position is not suitable, the occlusion device is re-received into the delivery catheter by the delivery guide wire Inside, the two parts are displayed at the distal end of the indicator, the position of the delivery catheter is re-adjusted under X-ray monitoring, and the delivery catheter is released to release the occlusion device until Under DSA development, it is observed that the position of the occlusion device just reaches the preset position; the occlusion device is used to transport the guide wire handle, the position of the shaft of the delivery guide wire is fixed, and the detachment of the guide wire outer tube is released and blocked.
  • Guide wire traverse delivery guide wire; after observing the blood patency of the place by contrast imaging technique, the occlusion device delivery catheter is evacuated, that is, the delivery and release process of the occlusion device is completed;
  • the guide wire is sent to the aortic aneurysm lesion site, and the position of the stent is conveyed by the far and near end of the guide wire and the visibility of the positioning indicator under X-ray confirms that the position of the stent delivery system is appropriate;
  • the fixed stent transports the guide wire, and the delivery catheter is At the time of withdrawal, the stent begins to release and expand; the visibility of the stent at the distal end of the stent is confirmed to be located at the opening of the aortic aneurysm; the stent is transported to the stent, and the blood patency of the stent is observed by contrast technique.
  • the stent delivery catheter is withdrawn from the body.
  • the size of the specific bracket and blocking device can be adjusted according to actual needs. The operation is small in trauma to the patient.
  • the two plates are located on both sides of the intima of the aortic aneurysm, blocking the opening of the dissection, cutting off the branch blood flow, preventing the aortic aneurysm from continuing to tear;
  • the function of the fixed occlusion device ensures the strength of the vascular segment of the aneurysm and the normal flow of blood in the blood vessel.
  • the combination of the two can achieve the purpose of curing the aortic aneurysm, and the success rate of the operation is high.

Abstract

An aortic aneurysm dissection stent system comprises a stent (1) and a plugging device (6) separated from each other, a stent conveying system, and a plugging device conveying system. By using the stent (1) and the plugging device (6) separated from each other in a cooperation way, the plugging device (6) is pushed to a lesion position through the plugging device conveying system, is released and unfolded to plug a cut on a blood vessel wall, to isolate a parent artery of an aorta (16) from a dissection (17) and to change the haemodynamics of the lesion part of an aortic aneurysm; and the stent (1) is pushed to the lesion part through the stent conveying system, is released and unfolded to support the inner wall of a blood vessel and the plugging device (6), so as to ensure that the plugging device (6) is firm and is not displaced under the impact of blood and a surgery is safer and more effective. In addition, since the conveying processes of the plugging device (6) and the stent (1) are separated, the size of a puncture point for a minimally invasive surgery and the diameter of a conveying sheath are greatly reduced, thereby preventing excessive damage to the artery.

Description

主动脉瘤夹层支架系统及其制备方法  Aortic aneurysm sandwich scaffold system and preparation method thereof
技术领域 Technical field
本发明涉及新型医疗器械,特别是用于植入治疗主动脉瘤的夹层支架系统及其制备方法。 背景资料  The invention relates to a novel medical device, in particular to a sandwich stent system for implanting aortic aneurysm and a preparation method thereof. Background information
主动脉夹层动脉瘤是主动脉瘤中最为危险的一种, 一般是指动脉的高压血流由主动脉内 膜撕裂处进入动脉壁中层, 使内、 外层分离并沿中层扩展形成 "夹层 "样结构的动脉瘤。 高压 血流向内压迫内膜縮窄以致阻塞了主动脉真腔, 向外使薄弱的主动脉壁膨出, 严重者可造成 破裂。 造成主动脉夹层动脉瘤的原因除了内膜撕裂性损伤外, 中层的退行性变, 组织粘合力 降低等也是重要的原因。 根据分类方法不同, 主动脉瘤夹层可分为不同几种, Stanford 分型 可分为 A型和 B型; Debakey分类可分为 I型、 II型和 III型。 Stanford A型相当于 Debakey I 型和 II型, 约占夹层动脉瘤的 65-70%; Stanford B型相当于 Debakey III型, 约占 30-35%。 主 动脉瘤夹层常见死因为破裂失血, 心包填塞、 心率失常或肾功能衰竭。 主动脉夹层动脉瘤病 情异常凶险, 发生夹层动脉瘤后 24小时生存率仅 40%, 1星期生存率为 25%, 3个月生存率 仅 10%。 病变累及升主动脉者预后更差, 1个月生存率仅 8%, 而病变仅累及胸降主动脉者则 1个月生存率可达 75%。  Aortic dissection aneurysm is the most dangerous type of aortic aneurysm. Generally, the high blood flow of the artery enters the middle layer of the artery wall from the tear of the aortic intima, separating the inner and outer layers and expanding along the middle layer to form a "mezzanine. "A structure of an aneurysm. The high pressure blood flow inwardly compresses the intima to narrow the obstruction of the aorta, causing the weak aortic wall to bulge outwards, which can cause rupture. In addition to the intimal tearing injury, the degeneration of the middle layer and the decrease of tissue adhesion are also important causes of aortic dissection. According to different classification methods, aortic aneurysm can be divided into several types. Stanford classification can be divided into type A and type B; Debakey classification can be divided into type I, type II and type III. Stanford type A is equivalent to Debakey type I and type II, accounting for approximately 65-70% of dissecting aneurysms; Stanford type B is equivalent to Debakey type III, accounting for approximately 30-35%. Common aneurysm dissection is often due to rupture of blood loss, pericardial tamponade, arrhythmia or renal failure. The aortic dissection aneurysm is extremely dangerous. The 24-hour survival rate after dissection of the aneurysm is only 40%, the 1-week survival rate is 25%, and the 3-month survival rate is only 10%. The prognosis of patients with lesions involving the ascending aorta is worse, with a 1-month survival rate of only 8%, and a one-month survival rate of up to 75% in patients with lesions involving only the descending thoracic aorta.
迄今为止, 尚无治疗夹层动脉瘤的有效药物, 手术是预防夹层动脉瘤破裂的惟一有效方 法。 以前, 由于没有合适的血管替代物, 夹层动脉瘤几乎是不治之症。 20世纪 50年代后期, 人工血管出现了, 并逐渐发展出了有效的传统手术方法一一人工血管置换术。 人工血管置换 术的操作相当繁复, 创伤大, 出血多, 恢复慢, 并发症较多。 主动脉长期阻断对其他重要脏 器有直接的不良影响, 术后导致心肌梗塞、 肾功能衰竭、 截瘫等多种并发症。 90年代, 阿根 廷血管外科医生 Parodi开创了动脉瘤的微创治疗技术——腔内隔绝术。 腔内隔绝术的腔内是 指手术在动脉腔内完成, 它不需要开胸, 仅在腹股沟部切一小口, 在 X射线监视下, 将内含 合适规格的人工血管的导管, 由股动脉导入, 到达主动脉病变部位后, 将人工血管从导管中 释放出来, 带有镍钛合金支架的人工血管便会自动撑开, 牢牢固定于主动脉内壁, 并将裂口 完全封闭, 假腔内残留的静止血液会逐渐血栓化, 并最终化为疤痕。  To date, there is no effective drug for the treatment of dissection aneurysms, and surgery is the only effective way to prevent rupture of dissection aneurysms. Previously, dissection aneurysms were almost incurable because there were no suitable vascular substitutes. In the late 1950s, artificial blood vessels appeared, and an effective traditional surgical method, artificial blood vessel replacement, was gradually developed. The operation of artificial blood vessel replacement is quite complicated, with large trauma, more bleeding, slow recovery, and more complications. Long-term aortic blockade has a direct adverse effect on other important organs, resulting in multiple complications such as myocardial infarction, renal failure, and paraplegia. In the 1990s, Argentine vascular surgeon Parodi pioneered a minimally invasive treatment of aneurysms, endovascular exclusion. Endovascular exclusion is performed in the lumen of the artery. It does not require a thoracotomy. It only cuts a small opening in the groin. Under X-ray monitoring, a catheter containing a suitable size of artificial blood vessels is placed from the femoral artery. After introduction, after reaching the aortic lesion, the artificial blood vessel is released from the catheter, and the artificial blood vessel with the Nitinol stent is automatically opened, firmly fixed to the inner wall of the aorta, and the gap is completely closed. The residual resting blood will gradually become thrombotic and eventually become scarred.
主动脉腔内支架植入术治疗主动脉夹层和夹层动脉瘤是近年来介入领域的一项进展。 主 动脉夹层的治疗目标是隔绝近端的主动脉裂口, 从而打开真腔, 封堵假腔, 使假腔内形成血 栓。 但是如果操作不当, 会导致夹层的逆向撕裂, 造成主动脉弓甚至升主动脉的夹层这一灾 难性的并发症。 将支架放置于相对脆弱的夹层主动脉壁和放置于动脉粥样硬化的动脉瘤血管 壁可能导致完全不同的结果。 在后者, 支架瞄定区仅需要一小段相对正常的血管壁就可以完 成; 但是主动脉夹层既需要更好的瞄定, 但也不能对血管壁损伤过大。 另外, 支架还需要一 定的顺应性, 这样可以保证真腔能够逐渐地扩张, 而假腔被不断地压縮, 这样才能保证治疗 的成功。 一些文献报道, 腔内支架技术治疗马凡综合症引起的胸主动脉瘤夹层效果不理想。 临床结果表明, 夹层血管壁被撕裂为多个真假腔, 而且支架跨越了真假腔, 尽管夹层破口被 修复, 但支架性血管并没有将破口修复。 从 1991年开始, 腔内技术治疗胸主动脉瘤病变已经 取得很多的临床经验, 但是这项技目前远未成熟。 如何减小切口防止动脉损伤, 使得支架系 统更加柔顺以及安全保护装置的应用, 使得临床结果也值得进一步研究。 此外, 对于因结缔 组织病变发生主动脉夹层的患者专家不建议采用腔内治疗的方式。 发明内容 Aortic stenting for the treatment of aortic dissection and dissection aneurysms is a recent advancement in interventions. The treatment goal of the aortic dissection is to isolate the proximal aortic rupture, thereby opening the true cavity, sealing the false lumen, and forming a thrombus in the false lumen. However, if it is not handled properly, it will cause the reverse tear of the interlayer, causing the dissection of the aortic arch or even the ascending aorta. Difficult complications. Placing the stent in the relatively fragile dissection of the aortic wall and placement on the atherosclerotic aneurysm vessel wall may result in completely different results. In the latter case, the stent-targeting zone requires only a small portion of the relatively normal vessel wall; however, the aortic dissection requires both a better orientation and no excessive damage to the vessel wall. In addition, the stent also requires a certain degree of compliance, which ensures that the true cavity can be gradually expanded, and the false lumen is continuously compressed, so as to ensure the success of the treatment. Some literature reports that the effect of endoluminal stenting on the treatment of thoracic aortic aneurysm caused by Marfan syndrome is not ideal. Clinical results showed that the sandwich vessel wall was torn into multiple true and false lumens, and the stent spanned the true and false lumens. Although the dissection was repaired, the stent vessels did not repair the fracture. Since 1991, intraluminal techniques have been used to treat thoracic aortic aneurysm lesions, but this technique is far from mature. How to reduce the incision to prevent arterial injury, make the stent system more compliant and the application of safety devices, so that the clinical results are worthy of further study. In addition, endovascular treatment is not recommended for patient specialists with aortic dissection due to connective tissue lesions. Summary of the invention
为解决上述问题, 本发明提供一种提供主动脉瘤夹层支架系统及其制备方法。  In order to solve the above problems, the present invention provides a system for providing an aortic aneurysm sandwich stent and a method for preparing the same.
主动脉瘤夹层支架系统, 其特征在于包括分离的支架与封堵装置, 还包括支架输送系统 和封堵装置输送系统, 所述支架由支架编织丝编织而成, 释放状态下为与所述主动脉瘤夹层 处血管内壁相适配的圆筒状结构, 所述封堵装置包括封堵装置网体, 所述封堵装置网体由封 堵装置编织丝编织而成, 释放状态下具有封住主动脉瘤血管壁开口的封堵面, 所述支架输送 系统包括支架输送导管和其远端用于装配和输送支架、 输送状态下穿过支架输送导管到达主 动脉瘤夹层处血管的支架输送导丝, 所述封堵装置输送系统包括远端具有定位标记的封堵装 置输送导管和其远端用于固定和释放封堵装置、 输送状态下从封堵装置输送导管中穿过到达 主动脉瘤血管壁开口处的封堵装置输送导丝。  The aortic aneurysm stent system includes a separate stent and an occlusion device, and further includes a stent delivery system and a occlusion device delivery system, the stent is woven from the stent braided wire, and the release state is the same as the main a cylindrical structure in which the inner wall of the aneurysm is fitted, the occlusion device comprises a occlusion device net body, and the net body of the occlusion device is woven by a tying device, and is sealed in a released state. The occlusion surface of the aortic aneurysm wall opening, the stent delivery system comprising a stent delivery catheter and a distal end thereof for assembling and delivering the stent, and a stent delivery guide for transporting the vessel through the stent delivery catheter to the aortic aneurysm The occlusion device delivery system includes a occlusion device delivery catheter having a locating marker at the distal end and a distal end thereof for fixing and releasing the occlusion device, and a delivery catheter from the occlusion device to the aortic aneurysm A occlusion device at the opening of the vessel wall delivers a guidewire.
所述支架具有收縮性, 释放状态下外形为网状圆筒形, 输送状态下收縮固定于支架输送 导丝上并从支架输送导管内腔输送至主动脉瘤夹层处。  The stent has contractility, and has a mesh-like cylindrical shape in a released state, and is contracted and fixed on the stent delivery guide wire in a delivery state and transported from the lumen of the stent delivery catheter to the aortic aneurysm.
所述支架长度方向两端边缘上有支架示标, 所述支架示标材质为铂合金、 镍钛合金或金 合金, 通过焊接的方式与所述支架编织丝固定连接, 所述支架输送导丝上固定有与支架示标 对应的支架输送导丝示标。  a bracket indicator is disposed on the two ends of the length direction of the bracket, and the bracket is made of a platinum alloy, a nickel-titanium alloy or a gold alloy, and is fixedly connected to the bracket braided wire by welding, and the bracket conveys a guide wire. A stent delivery guidewire indicator corresponding to the stent indicator is fixed on the upper surface.
所述支架输送导丝用生物高分子材料制成,其外径为 2.37-2.41mm,内径为 1.02-1.06mm, 中间有 0.036"-0.040"的导引导丝通过, 长度为 900-1000mm。  The stent delivery guide wire is made of a biopolymer material having an outer diameter of 2.37-2.41 mm, an inner diameter of 1.02-1.06 mm, a guide wire of 0.036"-0.040" in the middle, and a length of 900-1000 mm.
所述支架输送导管用生物高分子材料制成,其外径为 0.60mm至 1.80mm,内径为 0.35mm 至 1.20mm。  The stent delivery catheter is made of a biopolymer material having an outer diameter of 0.60 mm to 1.80 mm and an inner diameter of 0.35 mm to 1.20 mm.
所述支架采用镍钛金丝、钛丝、钨丝、 NITI丝、钽丝、不锈钢丝与铂的复合材料丝、 NITI 与金的复合材料丝中的一种或几种支架编织丝编织而成, 所述支架编织丝直径为 0.020mm至 0.060mm,数量为 1根,支架完全释放后的外径尺寸为 6mm至 30mm,长度为 10mm至 50mm。 所述封堵装置网体释放状态下为具有形状记忆功能的层状双盘结构, 所述封堵面的外层 缝制医用阻流膜。 The bracket is made of nickel-titanium gold wire, titanium wire, tungsten wire, NITI wire, silk wire, composite wire of stainless steel wire and platinum, one or several kinds of bracket braided wires of NITI and gold composite wire. , the stent braided wire has a diameter of 0.020 mm to 0.060mm, the number is one, the outer diameter of the bracket after full release is 6mm to 30mm, and the length is 10mm to 50mm. The occlusion device has a layered double-disc structure with a shape memory function in a state in which the occlusion device is in a released state, and the outer surface of the occlusion surface is sewn with a medical refractory film.
所述封堵装置包括位于封堵装置封堵面的封堵装置远端示标、 双盘结构相对面的封堵装 置近端示标和连接于封堵装置近端示标的连接件, 所述封堵装置输送导丝自远端起依次包括 远端栓头、 中轴和接头, 外侧为外管, 所述外管用生物医用高分子材料制成, 所述远端栓头 一端与连接件在外管内腔中配合连接, 另一端与所述中轴通过焊接方式连接。  The occlusion device comprises a distal end indication of the occlusion device on the sealing surface of the occlusion device, a proximal end indication of the occlusion device on the opposite side of the double disc structure, and a connection member connected to the proximal end indication of the occlusion device, The guiding device conveying guide wire comprises a distal plug head, a middle shaft and a joint from the distal end, and an outer tube on the outer side, wherein the outer tube is made of biomedical polymer material, and the distal end of the distal plug is connected with the connecting piece. The tube is mated in the inner cavity, and the other end is connected to the central shaft by welding.
所述中轴为不锈钢或镍钛合金制成,所述外管内径为 1.0mm至 2.0mm,外径为 1.5mm至 2.5mm, 长度为 1000mm至 1500mm, 外管近端粘接一手柄, 中轴外径为 0.25mm至 0.8mm, 长度为 1200mm至 1800mm, 中轴远端有一锥形过渡段。  The central shaft is made of stainless steel or nickel-titanium alloy, the outer tube has an inner diameter of 1.0 mm to 2.0 mm, an outer diameter of 1.5 mm to 2.5 mm, a length of 1000 mm to 1500 mm, and a proximal end of the outer tube is bonded to a handle. The outer diameter of the shaft is 0.25 mm to 0.8 mm, the length is 1200 mm to 1800 mm, and the distal end of the central shaft has a tapered transition section.
所述封堵装置远端示标和封堵装置近端示标材质为铂合金、镍钛合金、不锈钢或金合金, 所述封堵装置编织丝和封堵装置远端示标以及封堵装置近端示标通过焊接的方式固定连接。  The proximal indicator of the distal marking and blocking device of the occlusion device is made of platinum alloy, nickel-titanium alloy, stainless steel or gold alloy, and the distal end of the tying device and the occlusion device of the occlusion device and the occlusion device The proximal indicator is fixedly connected by soldering.
所述封堵装置输送导管用生物高分子材料制成, 内径 2mm至 5mm, 外径为 2.5mm至 6mm, 远端装有封堵装置输送导管远端示标。  The occlusion device delivery catheter is made of a biopolymer material having an inner diameter of 2 mm to 5 mm and an outer diameter of 2.5 mm to 6 mm, and the distal end is provided with a distal end of the occlusion device delivery catheter.
所述封堵装置网体采用镍钛金丝、 钛丝、 钨丝、 NiTi丝、 钽丝、 不锈钢丝与钽的复合材 料丝、 NiTi与金的复合材料丝中的一种或几种封堵装置编织丝编织而成, 所述封堵装置编织 丝直径为 0.05mm至 0.1mm, 数量为 8至 288根, 所述封堵装置网体完全释放后的双盘直径 尺寸为 2mm至 10mm。  The occlusion device net body adopts one or more kinds of nickel-titanium gold wire, titanium wire, tungsten wire, NiTi wire, filature wire, composite wire of stainless steel wire and bismuth, and composite wire of NiTi and gold. The woven wire of the device is woven by a diameter of 0.05 mm to 0.1 mm, and the number is 8 to 288. The diameter of the double disk after the net body of the occlusion device is completely released is 2 mm to 10 mm.
上述主动脉瘤夹层支架系统的制备方法, 其特征在于包括以下步骤: A.支架编织与定型, 将支架编织丝在支架编织模具上手工编织支架, 编织过程中在支架两端放上支架示标; 将编 织完成的支架连同模具进行热处理定型, 热成型后将支架从模具上取下, 将支架与支架示标 用焊接连接起来; B.支架输送导丝制作, 在挤管机上挤出塑料管, 将塑料管装配好后在流变 机上将塑料管熔合起来, 制管完成后在注塑机上注塑接头; C.编织封堵装置网体, 将封堵装 置编织丝在编织机上编织, 使封堵装置编织丝均匀分布; D.封堵装置制作, 将封堵装置网体 装上封堵装置成型模具, 然后将装模后的封堵装置网体进行热处理定型, 热成型后将模具从 封堵装置网体中取出来, 封堵装置网体两端装上封堵装置远端示标和封堵装置近端示标, 封 堵装置近端示标内装上连接件, 将封堵装置网体和封堵装置远端示标和封堵装置近端示标用 焊接方式焊接, 焊接好后的封堵装置网体缝上阻流膜; E.封堵装置输送导丝中轴制作: 将合 金丝置于不锈钢直尺上量好长度, 用斜口钳对合金丝进行下料, 将中轴的一端在外圆磨床上 磨削, 将栓头与封堵装置输送导丝用焊接方式连接。  The method for preparing the aortic aneurysm sandwich stent system comprises the following steps: A. stent weaving and sizing, the stent braided wire is manually woven on the stent woven mold, and the stent is placed on both ends of the stent during the weaving process. The woven finished stent is heat treated and shaped together with the mold. After the thermoforming, the bracket is removed from the mold, and the bracket and the bracket indicator are welded by welding; B. The stent is conveyed by a guide wire, and the plastic tube is extruded on the tube extruder. After assembling the plastic pipe, the plastic pipe is fused on the rheometer, and the joint is injected on the injection molding machine after the pipe is completed; C. The mesh body of the woven plugging device is woven, and the braiding wire of the plugging device is woven on the knitting machine to seal The braided wire of the plugging device is evenly distributed; D. The plugging device is prepared, the net body of the plugging device is mounted on the forming device of the plugging device, and then the mesh body of the plugging device after the molding is heat-treated and shaped, and the mold is sealed after thermoforming. The plugging device is taken out from the net body, and the two ends of the netting device of the plugging device are equipped with a distal end marking device and a proximal end indicating device for the blocking device, and the closing device is shown at the proximal end. The connecting piece is installed inside, and the netting device of the plugging device and the distal end of the plugging device and the proximal end of the plugging device are welded by welding, and the meshing body of the plugging device after welding is sealed with a choke film; The shaft is made by the plugging device. The alloy wire is placed on the stainless steel ruler to measure the length. The alloy wire is cut with the diagonal pliers. One end of the middle shaft is ground on the cylindrical grinding machine, and the plug and the seal are sealed. The blocking device conveying guide wire is connected by welding.
所述热处理采用真空热处理炉, 在 50CTC的条件下保温 30分钟; 所述焊接采用激光焊接 机或 TIG焊接方式焊接。 技术效果: The heat treatment is performed by a vacuum heat treatment furnace under the condition of 50 CTC for 30 minutes; the welding is performed by a laser welding machine or a TIG welding method. Technical effect:
与现有技术相比, 主动脉瘤夹层支架系统利用分离的支架与封堵装置配合使用, 通过封 堵装置输送导丝与封堵装置连接起来, 通过封堵装置输送导管推送到病变部位, 释放张开后 堵住血管壁开口处, 隔离主动脉载瘤动脉与夹层, 改变主动脉瘤病变部位血流动力学; 通过 支架输送系统将支架推送到病变部位, 释放张开后支撑血管内壁及封堵装置, 保证封堵装置 的牢固性, 不至于在血流的冲击作用下移位, 使得手术更加安全有效; 此外, 由于封堵装置 与支架的输送过程分离, 使得微创手术穿刺点以及输送鞘的直径大大减小, 防止动脉损伤过 大。  Compared with the prior art, the aortic aneurysm stent system utilizes a separate stent and a occlusion device, and the guide wire is connected to the occlusion device through the occlusion device, and is pushed to the lesion through the occlusion device delivery catheter, and released. After opening, the opening of the vessel wall is blocked, the aortic artery and the dissection are isolated, and the hemodynamics of the aortic aneurysm is changed. The stent is pushed to the lesion by the stent delivery system, and the inner wall of the vessel is supported after being released. The blocking device ensures the firmness of the occlusion device and does not shift under the impact of blood flow, which makes the operation safer and more effective. In addition, due to the separation of the occlusion device and the stent, the minimally invasive surgical puncture point and delivery The diameter of the sheath is greatly reduced to prevent excessive arterial damage.
本发明的支架输送导丝其柔韧性与推送性能好, 远端柔软, 能够在复杂的血管中自由输 送且不损伤血管内壁; 近端坚硬, 能够提供良好的推送性能; 支架输送导管其柔韧性好, 能 够在复杂的血管中自由输送且不损伤血管内壁; 封堵装置输送导管柔韧性和抗折性好, 能够 在复杂的血管中自由输送。  The stent delivery guide wire of the invention has good flexibility and pushing performance, is soft at the distal end, can be freely transported in complicated blood vessels and does not damage the inner wall of the blood vessel; the proximal end is hard and can provide good push performance; the flexibility of the stent delivery catheter is flexible Well, it can freely transport in complex blood vessels without damaging the inner wall of the blood vessel; the occlusion device delivers a flexible catheter and a good folding resistance, and can be freely transported in complex blood vessels.
主动脉瘤夹层支架系统制备过程中, 对于支架及封堵装置成型过程中采用真空热处理工 艺, 保证封堵装置材料形状记忆性能及弹性的同时, 使材料不被氧化以及产生材料内应力而 变形; 支架输送导管与封堵装置输送导管管身采用钢丝网与弹簧结合加强, 保证管身抗拉强 度的同时具有良好的抗折性, 能够在弯曲的血管内保证不发生弯折与损伤血管内膜; 封堵装 置网管与栓头采用激光焊接或 TIG焊接工艺, 保证焊接强度牢固。 附图说明  During the preparation of the aortic aneurysm stent system, a vacuum heat treatment process is adopted during the molding process of the stent and the occlusion device to ensure the shape memory property and elasticity of the occlusion device, and the material is not oxidized and deformed by the internal stress of the material; The stent delivery catheter and the occlusion device The delivery catheter tube body is reinforced with a steel mesh and a spring to ensure the tensile strength of the tube body and has good bending resistance, and can ensure bending and damage of the endovascular membrane in the curved blood vessel. The plugging device network tube and plug head adopt laser welding or TIG welding process to ensure the welding strength is firm. DRAWINGS
图 1本发明的支架示意图,  Figure 1 is a schematic view of a stent of the present invention,
图 2本发明支架与支架输送导丝示意图,  Figure 2 is a schematic view showing the guide wire of the stent and the stent of the present invention,
图 3本发明专利支架的输送装置结构图,  Figure 3 is a structural view of the conveying device of the patent holder of the present invention,
图 4本发明的封堵装置示意图,  Figure 4 is a schematic view of the occlusion device of the present invention,
图 5本发明封堵装置输送导丝装配示意图,  Figure 5 is a schematic view showing the assembly of the guide wire of the occlusion device of the present invention,
图 6本发明专利封堵装置的输送装置结构图,  Figure 6 is a structural view of the conveying device of the patented occlusion device of the present invention,
图 7主动脉瘤夹层封堵装置放置前示意图,  Figure 7 is a schematic view of the aortic aneurysm sandwich device before placement,
图 8主动脉瘤夹层封堵装置输送过程示意图,  Figure 8 Schematic diagram of the delivery process of the aortic aneurysm sandwich device
图 9主动脉瘤夹层封堵装置放置后示意图,  Figure 9 is a schematic view of the aortic aneurysm sandwich device after placement,
图 10主动脉瘤夹层支架输送过程示意图,  Figure 10 Schematic diagram of the aortic aneurysm stent graft delivery process,
图 11主动脉瘤夹层支架放置后示意图,  Figure 11 Schematic diagram of the placement of the aortic aneurysm sandwich stent,
图 12发明主动脉瘤夹层支架系统实施例编织网管示意图,  12 is a schematic view showing a braided mesh tube of an embodiment of the aortic aneurysm sandwich stent system;
图 13发明主动脉瘤夹层支架系统实施例封堵装置成型模具结构图, 附图中各标号列示如下: Figure 13 is a structural view of a molding die of an occlusion device of the embodiment of the aortic aneurysm sandwich stent system, The numbers in the drawings are listed below:
1-支架, 2a-支架近端示标, 2b-支架远端示标, 3a-支架输送导丝远端示标, 3b-支架输送 导丝定位示标, 3c-支架输送导丝近端示标, 4-支架输送导丝, 5-支架输送导管, 6-封堵装置 网体, 7-封堵装置远端示标, 8-封堵装置近端示标, 9-连接件, 10-远端栓头, 11-中轴, 12- 外管, 13-封堵装置输送导丝接头, 14-封堵装置输送导管, 15-封堵装置输送导管远端示标, 16-主动脉, 17-主动脉瘤夹层, 18-封堵装置输送导丝。 具体实施方式  1-bracket, 2a-bracket proximal end labeling, 2b-bracket distal labeling, 3a-bracket delivery guide wire distal marking, 3b-bracket conveying guide wire positioning indicator, 3c- stent delivery guide wire proximal end Standard, 4-bracket delivery guide wire, 5-bracket delivery catheter, 6-plugging device mesh, 7-blocking device distal marking, 8-blocking device proximal marking, 9-connector, 10- Distal plug, 11-axis, 12-outer tube, 13-plug device delivery guide wire connector, 14-plug device delivery catheter, 15-plug device delivery catheter distal indicator, 16-aorta, 17-Aortic aneurysm dissection, 18-occlusion device delivers guidewire. detailed description
下面结合附图和具体实施例对本发明做进一步详细说明。  The present invention will be further described in detail below with reference to the accompanying drawings and specific embodiments.
本实施例的主动脉瘤夹层支架系统包括支架与封堵装置两部分, 并分别包括支架输送系 统和封堵装置的输送系统, 具体结构如下:  The aortic aneurysm stent system of the present embodiment comprises a stent and a occlusion device, and respectively comprises a stent delivery system and a delivery system of the occlusion device, and the specific structure is as follows:
如图 1所示, 支架 1为采用超弹性 NITI合金丝的网状结构, 当然用其他可形成径向收縮 性的编织丝也可以, 其上包括支架近端示标 2a和支架远端示标 2b。 如图 2所示, 支架输送 导丝 4有三个示标即支架输送导丝远端示标 3a, 支架输送导丝定位示标 3b和支架输送导丝 近端示标 3c。 如图 3所示, 在输送状态下, 将支架 1装配在支架输送导丝 4上, 沿支架输送 导管 5内腔通过。支架远端示标 2b与支架输送导丝远端示标 3a重合, 支架近端示标 2a与支 架输送导丝近端示标 3c重合。 在到达预定位置后, 将支架输送导管 5往回撤, 支架 1便从支 架输送导管 5内释放出来, 超弹性 NITI合金丝会自动膨胀张开成原来的网状结构。  As shown in Fig. 1, the bracket 1 is a mesh structure using a superelastic NITI alloy wire, and of course, other braided wires capable of forming a radial contraction may be used, including a bracket proximal end indicator 2a and a bracket distal end labeling. 2b. As shown in Fig. 2, the stent delivery guide wire 4 has three indicators, that is, the stent delivery guide wire distal indicator 3a, the stent delivery guide wire positioning indicator 3b, and the stent delivery guide wire proximal indicator 3c. As shown in Fig. 3, in the delivery state, the stent 1 is assembled on the stent delivery guide wire 4 and passed through the lumen of the stent delivery catheter 5. The distal end marker 2b of the stent coincides with the distal marker 3a of the stent delivery guidewire, and the proximal marker 2a of the stent coincides with the proximal marker 3c of the stent delivery guidewire. After reaching the predetermined position, the stent delivery catheter 5 is withdrawn, the stent 1 is released from the stent delivery catheter 5, and the superelastic NITI alloy wire is automatically expanded to open the original mesh structure.
如图 4所示,本实施例的封堵装置也采用超弹性 NITI合金丝或其他有记忆功能的编织丝 制成, 其上包括封堵装置网体 6, 封堵装置远端示标 7, 封堵装置近端示标 8和连接件 9。 如 图 5所示, 封堵装置输送导丝 18包括远端栓头 10, 中轴 11, 外管 12和接头 13。 输送导丝 远端栓头 10与封堵装置连接件 9在输送导丝外管 12内腔中配合连接起来, 输送导丝中轴 11 与远端栓头 10通过焊接方式连接在一起。将输送导丝外管 12往回撤时, 远端栓头 10与封堵 装置连接件 9配合松开, 封堵装置网体 6即可脱离输送导丝。 如图 6所示, 输送状态将装有 封堵装置网体 6的封堵装置输送导丝 18沿封堵装置输送导管 14内腔通过, 推送封堵装置输 送导丝 18直至 DSA显影下观察到封堵装置远端示标 7与封堵装置输送导管远端示标 15重合。 将封堵装置输送导管 14往回撤, 封堵装置网体 6便从输送导管内释放出来, 超弹性 NITI合 金丝便会自动膨胀张开成原来的形状。  As shown in FIG. 4, the occlusion device of the present embodiment is also made of a superelastic NITI alloy wire or other woven wire having a memory function, and includes a occlusion device net body 6 and a distal end indication plate 7 of the occlusion device. The closure device has a proximal indicator 8 and a connector 9. As shown in Fig. 5, the occlusion device delivery guide 18 includes a distal plug 10, a central shaft 11, an outer tube 12 and a joint 13. The delivery guide wire distal end plug 10 and the occlusion device connector 9 are cooperatively connected in the inner cavity of the delivery guide wire outer tube 12, and the delivery guide wire middle shaft 11 and the distal ferrule 10 are connected by welding. When the delivery guide wire outer tube 12 is withdrawn, the distal plug head 10 is loosened with the occlusion device connector 9, and the occlusion device mesh body 6 can be detached from the delivery guide wire. As shown in Fig. 6, in the delivery state, the occlusion device delivery guide wire 18 with the occlusion device mesh body 6 is passed along the lumen of the occlusion device delivery catheter 14, and the occlusion device is pushed to transport the guide wire 18 until it is observed under DSA development. The occlusion device distal indicator 7 coincides with the occlusion device delivery catheter distal indicator 15. The occlusion device delivery catheter 14 is withdrawn, and the occlusion device mesh body 6 is released from the delivery catheter, and the superelastic NITI alloy wire is automatically expanded and expanded into its original shape.
如图 7, 图 8和图 9所示为封堵装置网体的输送过程, 利用封堵装置输送导管远端示标 15在 X射线下的可见性将封堵装置输送导管 14沿主动脉 16推送到预定位置主动脉瘤夹层 17。 将装有封堵装置网体 6的封堵装置输送导丝 18送入输送导管 14内, 拧紧封堵装置输送 导丝接头 13固定输送导丝中轴 11和输送导丝外管 12的相对位置。 将输送导丝 18向前直至 封堵装置远端示标 7和封堵装置输送导管远端示标 15重合。 此时, 将输送导管 14回撤, 封 堵装置网体 6便开始释放, 在 DSA显影下, 通过封堵装置远端示标 7和封堵装置近端示标 8 在 X射线下的可见性, 调整好相应位置, 使得封堵装置网体 6两盘位于血管夹层内膜两边。 待封堵装置网体 6完全释放后, 松开封堵装置输送导丝接头 13, 将输送导丝外管 12往回撤, 解脱封堵装置网体 6, 撤回封堵装置输送导丝 18及封堵装置输送导管 14。此时封堵装置网体 6附于血管夹层内膜上, 网体封堵住血管夹层开口处。 As shown in Fig. 7, Fig. 8 and Fig. 9, the delivery process of the occlusion device mesh body, using the occlusion device to deliver the visibility of the catheter distal end 15 under X-rays, the occlusion device delivery catheter 14 along the aorta 16 Pushed to the aortic aneurysm 17 at a predetermined location. The occlusion device delivery guide wire 18 with the occlusion device mesh body 6 is fed into the delivery catheter 14, and the relative position of the delivery guide wire guide shaft 13 and the delivery guide wire outer tube 12 is tightened by tightening the occlusion device delivery guide wire connector 13. . Feed the guide wire 18 forward until The occlusion device distal indicator 7 and the occlusion device delivery catheter distal indicator 15 coincide. At this point, the delivery catheter 14 is withdrawn, and the occlusion device mesh 6 begins to be released. Under DSA development, the visibility of the distal indication 7 of the occlusion device and the proximal indicator 8 of the occlusion device under X-rays , adjust the corresponding position, so that the two devices of the occlusion device net body 6 are located on both sides of the inner membrane of the vascular sandwich. After the net body 6 of the occlusion device is completely released, the occlusion device is released to transport the guide wire connector 13, the outer guide tube 12 of the guide wire is retracted, the mesh body 6 of the occlusion device is released, and the guide wire 18 is withdrawn from the occlusion device. The occlusion device delivers the catheter 14. At this time, the occlusion device net body 6 is attached to the inner membrane of the vascular sandwich, and the mesh body blocks the opening of the vascular sandwich layer.
如图 10和图 11所示为支架的输送过程, 将支架 1装入支架输送导管 5中, 通过支架输 送导丝远端示标 3a, 定位示标 3b, 近端示标 3c及支架远端示标 2b和支架近端示标 2a在 X 射线下的可见性将支架 1输送预定位置。 保持支架输送导丝 4的位置不变, 将支架输送导管 5往回撤, 此时支架 1便开始释放, 待支架 1完全释放后, 撤回支架输送导丝 4及支架输送 导管 5, 此时支架 1如图 11所示附着于血管内壁上, 支撑起主动脉 16血管与封堵装置。  As shown in Fig. 10 and Fig. 11, the stent is transported, and the stent 1 is loaded into the stent delivery catheter 5, and the distal guide 3a of the guide wire is transported through the stent, the positioning indicator 3b, the proximal indicator 3c and the distal end of the stent are provided. The visibility of the indicator 2b and the stent proximal indicator 2a under X-rays conveys the stent 1 to a predetermined position. Keeping the position of the stent delivery guide wire 4 unchanged, the stent delivery catheter 5 is withdrawn, and the stent 1 is then released. After the stent 1 is completely released, the stent delivery guide wire 4 and the stent delivery catheter 5 are withdrawn. 1 Attached to the inner wall of the blood vessel as shown in Fig. 11, supporting the blood vessel of the aorta 16 and the occlusion device.
本实施例的主动脉夹层支架系统的使用具体步骤: 一、 临床确诊患者为主动瘤夹层患者 时, 对病人进行术前常规观察; 二、 对病人进行股动脉穿刺, 常规造影发现主动脉瘤病变位 置后, 将封堵装置输送导管 14经封堵装置输送导丝 18送至主动脉瘤夹层 17病变部位; 三、 撤回封堵装置输送导丝 18, 将封堵装置网体 6装入封堵装置输送导管 14中, 在 X射线监视 下往前推送封堵装置输送导丝 18直至封堵装置远端示标 Ί与封堵装置输送导管远端示标 15 重合; 四、 通过封堵装置输送导管远端示标 15在 X射线下的可见性确认封堵装置输送导管 14与封堵装置输送导丝 18远端已通过主动瘤夹层开口, 进入到血管夹层中; 五、 固定封堵 装置输送导丝 18, 将封堵装置输送导管 14往回撤, 此时封堵装置网体 6开始释放膨胀, 通 过封堵装置远近端示标 8、 7在 X射线下的可见性来确定封堵装置网体 6的两盘是否位于主 动脉瘤夹层 17内膜的两边,堵住夹层开口处;若位置合适即完成封堵装置网体 6的释放过程, 若位置不合适, 则通过封堵装置输送导丝 18将封堵装置网体 6重新收入封堵装置输送导管 14内使得两部件远端示标重合; 在 X射线监视下重新调整封堵装置输送导管 14的位置, 回 撤封堵装置输送导管 14释放封堵装置网体 6, 直至在 DSA显影下观察到封堵装置网体 6的 位置刚好达到预设位置即可; 六、 松开封堵装置输送导丝 13接头, 回撤输送导丝外管 12使 得封堵装置网体 6与输送导丝中轴 11解脱分离, 回撤封堵装置输送导丝 18; 七、 通过造影 技术观察该处的血液通畅性良好后, 将封堵装置输送导管 14撤离体外; 八、将装有支架 1的 支架输送导管 5经支架输送导丝 4送至主动脉瘤夹层 17病变部位; 九、通过支架输送导丝远 近端示标 3a、 3c及定位示标 3b在 X射线下的可见性确认支架输送系统的位置合适; 十、 固 定支架输送导丝 4, 将支架输送导管 5往回撤, 此时支架 1开始释放膨胀。 通过支架远近端 示标 2b、 2a在 X射线下的可见性确认支架 1位于主动脉瘤夹层 17开口处; ^一、 回撤支架 输送导丝 4, 通过造影技术观察该处的血液通畅性良好后, 将支架输送导管 5撤离体外。 制备方法 The specific steps of the aortic dissection stent system of the present embodiment are as follows: 1. When the clinically diagnosed patient is an active tumor dissection patient, the patient is routinely observed before surgery; 2. The patient is subjected to femoral artery puncture, and the conventional aneurysm is found to be aortic aneurysm lesion. After the position, the occlusion device delivery catheter 14 is sent to the lesion portion of the aortic aneurysm 17 through the occlusion device delivery guide wire 18; 3. The occlusion device is used to transport the guide wire 18, and the occlusion device mesh body 6 is inserted into the occlusion device. In the device delivery catheter 14, under the X-ray monitoring, the occlusion device is pushed forward to convey the guide wire 18 until the distal indication Ί of the occlusion device coincides with the distal indication 15 of the occlusion device delivery catheter; 4. The delivery device is transported by the occlusion device The visibility of the distal end of the catheter 15 under X-ray confirms that the occlusion device delivery catheter 14 and the distal end of the occlusion device delivery guide wire 18 have passed through the active tumor sandwich opening and into the vascular sandwich; 5. Fixed occlusion device delivery The guide wire 18 retracts the occlusion device delivery catheter 14 at which time the occlusion device mesh body 6 begins to release and expand, and the visibility of the distal and distal ends of the occlusion device 8 and 7 under X-rays is Whether the two plates of the netting device 6 of the blocking device are located on both sides of the inner membrane of the aortic aneurysm 17 and block the opening of the sandwich; if the position is appropriate, the release process of the netting device 6 is completed, and if the position is not suitable, the plate is passed. The occlusion device transports the guide wire 18 to re-integrate the occlusion device net body 6 into the occlusion device delivery catheter 14 so that the distal end of the two components are coincident; the position of the occlusion device delivery catheter 14 is re-adjusted under X-ray monitoring, and the retracement is retracted. The occlusion device delivery catheter 14 releases the occlusion device mesh body 6, until the position of the occlusion device mesh body 6 is just reached the preset position under the DSA development; 6. releasing the occlusion device to transport the guide wire 13 connector, The traverse delivery guide wire outer tube 12 is such that the occlusion device net body 6 is disengaged from the delivery guide wire shaft 11 and the retort occlusion device transports the guide wire 18; 7. After observing the blood patency of the place by contrast imaging technology, The occlusion device delivery catheter 14 is withdrawn from the body; 8. The stent delivery catheter 5 containing the stent 1 is delivered to the lesion portion of the aortic aneurysm 17 via the stent delivery guide wire 4; IX. The distal and distal end marker 3a is guided through the stent delivery guide wire 3c and 3b illustrates a suitable bit in the position marked visibility under X-ray confirmed the stent delivery system; ten fixed guide wire stent delivery 4, 5 to a stent delivery catheter pullback this time begins to release the stent 1 expanded. The stent 1 is located at the opening of the aortic aneurysm 17 by the visibility of the distal end markers 2b, 2a under the X-ray; ^1, the stent is transported to the guidewire 4, and the blood patency of the site is observed by contrast technique. Thereafter, the stent delivery catheter 5 is withdrawn from the body. Preparation
本实施例的制备方法包括以下步骤:  The preparation method of this embodiment includes the following steps:
一、 支架编织与热处理定型;  1. Bracket weaving and heat treatment shaping;
二、 支架输送导丝制作;  Second, the stent delivery guide wire is made;
三、 网体编织与封堵装置制作;  Third, the mesh body weaving and blocking device production;
四、 封堵装置输送导丝中轴制作;  4. The production of the guide shaft of the guiding device for the occlusion device;
支架编织与定型: 用一根直径为 0.14mm 的 NITI合金丝在支架编织模具上手工编织支 架, 编织过程中在支架两端放上铂铱合金丝绕制的示标; 将编织完成的支架连同模具放入武 汉工业电炉总厂制造的 ZSK2-12-6型真空热处理炉中热处理定型, 在 500°C的条件下保温 30 分钟; 热成型后将支架从模具上取下来, 将支架与示标用北京泽光电技术有限公司制造的 LCT-W1型激光焊接机或 TIG焊接方式焊接连接起来。  Bracket weaving and sizing: Hand-knit the bracket on the bracket woven mold with a diameter of 0.14mm NITI alloy wire. During the weaving process, a platinum-iridium alloy wire-wound indicator is placed on both ends of the bracket; The mold was placed in a ZSK2-12-6 vacuum heat treatment furnace manufactured by Wuhan Industrial Electric Furnace Plant for heat treatment and set at 500 °C for 30 minutes. After thermoforming, the bracket was removed from the mold, and the bracket and the indicator were placed. It is welded by LCT-W1 laser welding machine or TIG welding method manufactured by Beijing Ze Optoelectronic Technology Co., Ltd.
支架输送导丝制作: 将 Pebax材料颗粒烘干后, 在美国 America Kuhne . Inc公司制造 的 25机挤出设备组上挤出相应规格的塑料管, 将塑料管装配好后在格兰达技术(深圳)有限 公司生产的流变机上将几种塑料管熔合起来, 制管完成后在 Boy Machines Inc公司生产的立 式注塑机上注塑接头。  Bracket transport guide wire production: After drying the Pebax material pellets, the corresponding specifications of plastic tubes were extruded on a 25-machine extrusion equipment group manufactured by America Kuhne. Inc., and the plastic tubes were assembled after the Granada technology ( Several plastic pipes were fused on the rheometer produced by Shenzhen Co., Ltd. After the pipe was completed, the joints were injection molded on a vertical injection molding machine manufactured by Boy Machines Inc.
编织网体: 用 72 根 0.05mm 的 NITI 合金丝在深圳市惠泰医疗器械有限公司制造的 HTBZ-40型编织机上编织如图 12所示的网体, NITI丝均匀分布在网体上。  Braided mesh body: The mesh body shown in Figure 12 was woven on the HTBZ-40 braiding machine manufactured by Shenzhen Huitai Medical Instrument Co., Ltd. with 72 pieces of 0.05mm NITI alloy wire. The NITI wire was evenly distributed on the mesh body.
封堵装置制作: 根据图纸设计要求, 将网体装上如图 13所示的封堵装置成型模具; 然后 将装模后的编织网体放入武汉工业电炉总厂制造的 ZSK1-12-6 型真空热处理炉中热处理定 型, 在 50CTC的条件下保温 30分钟; 热成型后将模具从网体中取出来, 网体两端装上示标, 近端示标内装上连接件, 将网体和示标用北京泽光电技术有限公司制造的 LCT-W1型激光焊 接机或 TIG焊接方式焊接即可, 焊接好后的封堵装置缝上阻流膜即可制成完整的封堵装置。  Production of occlusion device: According to the design requirements of the drawings, the mesh body is mounted with the clogging device forming mold as shown in Fig. 13; then the woven mesh body after the molding is placed in ZSK1-12-6 manufactured by Wuhan Industrial Electric Furnace General Factory In the vacuum heat treatment furnace, the heat treatment is set, and the temperature is kept for 30 minutes under the condition of 50CTC; after the thermoforming, the mold is taken out from the net body, the ends of the net body are marked with a mark, and the proximal end of the display is equipped with a connecting piece, and the net body is attached. The indicator can be welded by LCT-W1 laser welding machine or TIG welding method manufactured by Beijing Ze Optoelectronic Technology Co., Ltd., and the sealing device after welding can be used to make a complete blocking device.
封堵装置输送导丝中轴制作: 用直径为 0.65mm的 NITI合金丝按图纸设计要求下料后, 将中轴的一端在美国 ROYAL MASTER GEINDERS.INC制造的 TG12X4型外圆磨床上磨削成 符合设计要求的形状,将按图纸设计要求采购的不锈钢栓头与导丝用 TIG焊接方式连接起来, 即完成封堵装置输送导丝中轴的制作。 应用举例:  The occlusion device conveys the guide wire to the middle shaft: After cutting the NITI alloy wire with a diameter of 0.65mm according to the design requirements of the drawings, one end of the middle shaft is ground into a TG12X4 cylindrical grinding machine manufactured by ROYAL MASTER GEINDERS.INC in the United States. In accordance with the shape of the design requirements, the stainless steel bolt head and the guide wire purchased according to the design requirements of the drawings are connected by TIG welding method, that is, the shaft of the guide wire for guiding the conveying device is completed. Application examples:
体内试验: 用长有主动脉瘤夹层的狗一只, 本发明的主动脉瘤夹层支架系统及其附属配 件一套, 支架直径为 10mm, 长度为 30mm; 支架输送导管内径为 2.48mm, 外径 2.97mm; 支架输送导丝内径为 1.63mm, 外径为 2.39mm, 中间能够通过 0.038"的导丝; 封堵装置盘面 直径为 6mm, 输送导丝中轴为 0.65mm, 输送导管内径为 1.8mm, 外径为 2.3mm; 经股动脉 进行穿刺,在血管造影术下确认主动脉瘤夹层病变部位后, 在 X射线监视下, 首先送入导丝, 通过导丝的引导作用将封堵装置输送导管推动到预设位置; 通过输送导管的远端示标判断导 管的位置是否正确, 撤回导丝, 将封堵装置通过装载器装入输送导管中, 将输送导丝往前输 送, 直至在 DSA显影技术下观察到封堵装置远端示标与输送导管远端示标重合; 固定封堵装 置输送导丝, 将输送导管往回撤, 此时封堵装置开始释放膨胀, 通过封堵装置远近两端的示 标在 X射线下的可见性来确定封堵装置的两盘是否位于动脉瘤夹层内膜的两侧; 若位置合适 即完成封堵装置的释放过程, 若位置不合适, 则通过输送导丝将封堵装置重新收入输送导管 内, 使得两部件远端示标重合, 在 X射线监视下重新调整输送导管的位置, 回撤输送导管释 放封堵装置, 直至在 DSA显影下观察到封堵装置的位置刚好达到预设位置即可; 松开封堵装 置输送导丝手柄, 固定输送导丝中轴的位置, 回撤输送导丝外管解脱封堵装置与输送导丝, 回撤输送导丝; 通过造影技术观察该处的血液通畅性良好后, 将封堵装置输送导管撤离体外, 即完成封堵装置的输送释放过程; 将装有支架的支架输送导管经导引导丝送至主动脉瘤夹层 病变部位, 通过支架输送导丝远近端示标及定位示标在 X射线下的可见性确认支架输送系统 的位置合适; 固定支架输送导丝, 将输送导管往回撤, 此时支架开始释放膨胀; 通过支架远 近端示标在 X射线下的可见性确认支架位于主动脉瘤夹层开口处; 回撤支架输送导丝, 通过 造影技术观察该处的血液通畅性良好后, 将支架输送导管撤离体外。 具体支架和封堵装置尺 寸根据实际需要可作出相应调整。 该手术对病人创伤小, 封堵装置释放后两盘位于主动脉瘤 夹层内膜两侧, 堵住夹层开口处, 切断分支血液流向, 阻止主动脉瘤夹层继续撕裂; 支架释 放后起到支撑固定封堵装置的作用, 同时保证动脉瘤血管段强度和血管内血液正常流动, 两 者配合达到治愈主动脉瘤夹层的目的, 手术成功率高。 In vivo test: A dog with a dissected aortic aneurysm, a set of aortic aneurysm stent system and its accessory accessories of the present invention, the stent has a diameter of 10 mm and a length of 30 mm; the stent delivery catheter has an inner diameter of 2.48 mm, and an outer diameter. 2.97mm; The inner diameter of the stent delivery guide wire is 1.63mm, the outer diameter is 2.39mm, and the middle can pass the guide wire of 0.038"; the diameter of the disk surface of the sealing device is 6mm, the axis of the delivery guide wire is 0.65mm, and the inner diameter of the delivery catheter is 1.8mm. , outer diameter of 2.3mm; transfemoral artery After puncture, after confirming the aortic aneurysm dissection lesion under angiography, under the X-ray monitoring, the guide wire is first fed, and the occlusion device delivery catheter is pushed to the preset position by the guiding action of the guide wire; The distal indicator determines whether the position of the catheter is correct, withdraws the guide wire, loads the occlusion device into the delivery catheter through the loader, and transports the delivery guide wire forward until the distal end of the occlusion device is observed under DSA development technology. The indicator is coincident with the distal indicator of the delivery catheter; the fixed occlusion device delivers the guide wire, and the delivery catheter is withdrawn. At this time, the occlusion device begins to release the expansion, and the indications at the ends of the occlusion device are visible under X-rays. To determine whether the two plates of the occlusion device are located on both sides of the intima of the aneurysm; if the position is appropriate, the release process of the occlusion device is completed, and if the position is not suitable, the occlusion device is re-received into the delivery catheter by the delivery guide wire Inside, the two parts are displayed at the distal end of the indicator, the position of the delivery catheter is re-adjusted under X-ray monitoring, and the delivery catheter is released to release the occlusion device until Under DSA development, it is observed that the position of the occlusion device just reaches the preset position; the occlusion device is used to transport the guide wire handle, the position of the shaft of the delivery guide wire is fixed, and the detachment of the guide wire outer tube is released and blocked. Guide wire, traverse delivery guide wire; after observing the blood patency of the place by contrast imaging technique, the occlusion device delivery catheter is evacuated, that is, the delivery and release process of the occlusion device is completed; The guide wire is sent to the aortic aneurysm lesion site, and the position of the stent is conveyed by the far and near end of the guide wire and the visibility of the positioning indicator under X-ray confirms that the position of the stent delivery system is appropriate; the fixed stent transports the guide wire, and the delivery catheter is At the time of withdrawal, the stent begins to release and expand; the visibility of the stent at the distal end of the stent is confirmed to be located at the opening of the aortic aneurysm; the stent is transported to the stent, and the blood patency of the stent is observed by contrast technique. After good, the stent delivery catheter is withdrawn from the body. The size of the specific bracket and blocking device can be adjusted according to actual needs. The operation is small in trauma to the patient. After the occlusion device is released, the two plates are located on both sides of the intima of the aortic aneurysm, blocking the opening of the dissection, cutting off the branch blood flow, preventing the aortic aneurysm from continuing to tear; The function of the fixed occlusion device ensures the strength of the vascular segment of the aneurysm and the normal flow of blood in the blood vessel. The combination of the two can achieve the purpose of curing the aortic aneurysm, and the success rate of the operation is high.
本发明的主动脉瘤夹层支架系统的设计研究及其制备方法, 不受上述实施例的限制, 凡 是利用本发明的结构和方式及制备方法, 根据具体病例经过变换尺寸和代换元件等所形成的 技术方案, 都在本发明的保护范围内。  The design study of the aortic aneurysm stent system of the present invention and the preparation method thereof are not limited by the above embodiments, and the structures and methods and preparation methods of the present invention are used, and the size and substitution components are formed according to specific cases. The technical solutions are all within the scope of the present invention.

Claims

权利要求书 Claim
1、 主动脉瘤夹层支架系统, 其特征在于包括分离的支架与封堵装置, 还包括支架输送系 统和封堵装置输送系统, 所述支架由支架编织丝编织而成, 释放状态下为与所述主动脉瘤夹 层处血管内壁相适配的圆筒状结构, 所述封堵装置包括封堵装置网体, 所述封堵装置网体由 封堵装置编织丝编织而成, 释放状态下具有封住主动脉瘤血管壁开口的封堵面, 所述支架输 送系统包括支架输送导管和其远端用于装配和输送支架、 输送状态下穿过支架输送导管到达 主动脉瘤夹层处血管的支架输送导丝, 所述封堵装置输送系统包括远端具有定位标记的封堵 装置输送导管和其远端用于固定和释放封堵装置、 输送状态下从封堵装置输送导管中穿过到 达主动脉瘤血管壁开口处的封堵装置输送导丝。  1. Aortic aneurysm stent system, characterized in that it comprises a separate stent and a occlusion device, and further comprises a stent delivery system and a occlusion device delivery system, the stent is woven from a stent braided wire, and is released under the state of release. a cylindrical structure adapted to the inner wall of the vessel at the aortic aneurysm, the occlusion device comprising a occlusion device mesh body, the occlusion device mesh body being woven by the occlusion device braided wire, having a release state A sealing surface sealing the opening of the aortic aneurysm wall, the stent delivery system comprising a stent delivery catheter and a distal end thereof for assembling and delivering the stent, and a stent for delivery to the vessel of the aortic aneurysm through the stent delivery catheter Transmitting a guide wire, the occlusion device delivery system includes a occlusion device delivery catheter having a positioning mark at a distal end and a distal end thereof for fixing and releasing the occlusion device, and passing through the delivery device from the occlusion device to the main delivery state A occlusion device at the opening of the vascular wall of the aneurysm delivers a guidewire.
2、根据权利要求 1所述的主动脉瘤夹层支架系统, 其特征在于所述支架具有收縮性, 释 放状态下外形为网状圆筒形, 输送状态下收縮固定于支架输送导丝上并从支架输送导管内腔 输送至主动脉瘤夹层处。  2. The aortic aneurysm stent system according to claim 1, wherein the stent has contractility, and has a mesh-like cylindrical shape in a released state, and is contracted and fixed on the stent delivery guide wire in a delivery state. The stent delivery catheter lumen is delivered to the aortic aneurysm.
3、根据权利要求 1所述的主动脉瘤夹层支架系统, 其特征在于所述支架长度方向两端边 缘上有支架示标, 所述支架示标材质为铂合金、 镍钛合金或金合金, 通过焊接的方式与所述 支架编织丝固定连接, 所述支架输送导丝上固定有与支架示标对应的支架输送导丝示标。  The aortic aneurysm stent system according to claim 1, wherein the stent has a stent on both ends of the longitudinal direction of the stent, and the stent is made of a platinum alloy, a nickel-titanium alloy or a gold alloy. The stent braided wire is fixedly connected by means of welding, and the stent delivery guide wire corresponding to the stent indicator is fixed on the stent delivery guide wire.
4、根据权利要求 1所述的主动脉瘤夹层支架系统, 其特征在于所述支架输送导丝用生物 高分子材料制成, 其外径为 2.37-2.41mm, 内径为 1.02-1.06mm, 中间有 0.036"-0.040"的导引 导丝通过, 长度为 900-1000mm。  The aortic aneurysm stent system according to claim 1, wherein the stent delivery guide wire is made of a biopolymer material, and has an outer diameter of 2.37-2.41 mm and an inner diameter of 1.02-1.06 mm. There is a guide wire of 0.036"-0.040", and the length is 900-1000mm.
5、根据权利要求 1所述的主动脉瘤夹层支架系统, 其特征在于所述支架输送导管用生物 高分子材料制成, 其外径为 0.60mm至 1.80mm, 内径为 0.35mm至 1.20mm, 管身采用钢丝 网与弹簧结合加强。  The aortic aneurysm stent system according to claim 1, wherein the stent delivery catheter is made of a biopolymer material having an outer diameter of 0.60 mm to 1.80 mm and an inner diameter of 0.35 mm to 1.20 mm. The pipe body is reinforced with a wire mesh and a spring.
6、 根据权利要求 1-5任一所述的主动脉瘤夹层支架系统, 其特征在于所述支架采用镍钛 金丝、 钛丝、 钨丝、 NITI丝、 钽丝、 不锈钢丝与铂的复合材料丝、 NITI与金的复合材料丝中 的一种或几种支架编织丝编织而成, 所述支架编织丝直径为 0.020mm至 0.060mm, 数量为 1 根, 支架完全释放后的外径尺寸为 6mm至 30mm, 长度为 10mm至 50mm。  The aortic aneurysm stent system according to any one of claims 1 to 5, characterized in that the stent is a composite of nickel-titanium gold wire, titanium wire, tungsten wire, NITI wire, silk wire, stainless steel wire and platinum. One or more kinds of stent braided wires of material filament, NITI and gold composite wire, the stent braided wire diameter is 0.020mm to 0.060mm, the number is one, and the outer diameter of the stent after complete release It is 6mm to 30mm and has a length of 10mm to 50mm.
7、根据权利要求 1所述的主动脉瘤夹层支架系统, 其特征在于所述封堵装置网体释放状 态下为具有形状记忆功能的层状双盘结构, 所述封堵面的外层缝制医用阻流膜。  The aortic aneurysm stent system according to claim 1, wherein the occlusion device has a layered double-disc structure having a shape memory function in a released state, and an outer layer of the sealing surface Medical choke.
8、根据权利要求 7所述的主动脉瘤夹层支架系统, 其特征在于所述封堵装置包括位于封 堵装置封堵面的封堵装置远端示标、 双盘结构相对面的封堵装置近端示标和连接于封堵装置 近端示标的连接件, 所述封堵装置输送导丝自远端起依次包括远端栓头、 中轴和接头, 外侧 为外管, 所述外管用生物医用高分子材料制成, 所述远端栓头一端与连接件在外管内腔中配 合连接, 另一端与所述中轴通过焊接方式连接。 The aortic aneurysm stent system according to claim 7, wherein the occlusion device comprises a distal end indication of the occlusion device on the sealing surface of the occlusion device, and a occlusion device on the opposite side of the double disc structure. a proximal indicator and a connector connected to the proximal end of the occlusion device, the occlusion device conveying the guide wire from the distal end including the distal ferrule, the central shaft and the joint, the outer side The outer tube is made of a biomedical polymer material, and one end of the distal plug is cooperatively connected with the connecting member in the inner tube inner cavity, and the other end is connected to the central shaft by welding.
9、根据权利要求 8所述的主动脉瘤夹层支架系统, 其特征在于所述中轴为不锈钢或镍钛 合金制成, 所述外管内径为 1.0mm至 2.0mm, 外径为 1.5mm至 2.5mm, 长度为 1000mm至 1500mm,外管近端粘接一手柄, 中轴外径为 0.25mm至 0.8mm, 长度为 1200mm至 1800mm, 中轴远端有一锥形过渡段。  The aortic aneurysm stent system according to claim 8, wherein the central shaft is made of stainless steel or nickel-titanium alloy, and the outer tube has an inner diameter of 1.0 mm to 2.0 mm and an outer diameter of 1.5 mm. 2.5mm, length from 1000mm to 1500mm, a handle attached to the proximal end of the outer tube, the outer diameter of the central shaft is 0.25mm to 0.8mm, the length is 1200mm to 1800mm, and the distal end of the central shaft has a tapered transition section.
10、 根据权利要求 8所述的主动脉瘤夹层支架系统, 其特征在于所述封堵装置远端示标 和封堵装置近端示标材质为铂合金、 镍钛合金、 不锈钢或金合金, 所述封堵装置编织丝和封 堵装置远端示标以及封堵装置近端示标通过焊接的方式固定连接。  10. The aortic aneurysm stent system according to claim 8, wherein the distal indicator of the distal end of the occlusion device and the occlusion device are made of platinum alloy, nickel titanium alloy, stainless steel or gold alloy. The occlusion device braiding wire and the distal end of the occlusion device and the proximal indicator of the occlusion device are fixedly connected by welding.
11、 根据权利要求 8所述的主动脉瘤夹层支架系统, 其特征在于所述封堵装置输送导管 用生物高分子材料制成, 内径 2mm至 5mm, 外径为 2.5mm至 6mm, 远端装有封堵装置输送 导管远端示标, 管身采用钢丝网与弹簧结合加强。  11. The aortic aneurysm stent system according to claim 8, wherein the occlusion device delivery catheter is made of a biopolymer material having an inner diameter of 2 mm to 5 mm and an outer diameter of 2.5 mm to 6 mm. The occlusion device has a distal end of the delivery catheter, and the tube body is reinforced with a steel mesh and a spring.
12、 根据权利要求 1、 7-11 任一所述的主动脉瘤夹层支架系统, 其特征在于所述封堵装 置网体采用钛丝、 钨丝、 NiTi丝、 钽丝、 不锈钢丝与钽的复合材料丝、 NiTi与金的复合材料 丝中的一种或几种封堵装置编织丝编织而成,所述封堵装置编织丝直径为 0.05mm至 0.1mm, 数量为 8至 288根, 所述封堵装置网体完全释放后的双盘直径尺寸为 2mm至 10mm。  The aortic aneurysm stent system according to any one of claims 1 to 7, wherein the occlusion device mesh body is made of titanium wire, tungsten wire, NiTi wire, filature wire, stainless steel wire and enamel. One or more kinds of plugging devices of composite wire, NiTi and gold composite wire are woven by braiding wire, the wire diameter of the blocking device is 0.05 mm to 0.1 mm, and the number is 8 to 288. The diameter of the double disc after the net body of the plugging device is completely released is 2 mm to 10 mm.
13、 权利要求 1-12所述主动脉瘤夹层支架系统的制备方法, 其特征在于包括以下步骤: A.支架编织与定型, 将支架编织丝在支架编织模具上手工编织支架, 编织过程中在支架两端 放上支架示标; 将编织完成的支架连同模具进行热处理定型, 热成型后将支架从模具上取下, 将支架与支架示标用焊接连接起来; B.支架输送导丝制作, 在挤管机上挤出塑料管, 将塑料 管装配好后在流变机上将塑料管熔合起来, 制管完成后在注塑机上注塑接头; C.编织封堵装 置网体, 将封堵装置编织丝在编织机上编织, 使封堵装置编织丝均匀分布; D.封堵装置制作, 将封堵装置网体装上封堵装置成型模具, 然后将装模后的封堵装置网体进行热处理定型, 热 成型后将模具从封堵装置网体中取出来, 封堵装置网体两端装上封堵装置远端示标和封堵装 置近端示标, 封堵装置近端示标内装上连接件, 将封堵装置网体和封堵装置远端示标和封堵 装置近端示标用焊接方式焊接, 焊接好后的封堵装置网体缝上阻流膜; E.封堵装置输送导丝 中轴制作: 将合金丝置于不锈钢直尺上量好长度, 用斜口钳对合金丝进行下料, 将中轴的一 端在外圆磨床上磨削, 将栓头与封堵装置输送导丝用焊接方式连接。  13. The method for preparing an aortic aneurysm stent system according to any of claims 1-12, comprising the steps of: A. stent weaving and shaping, the stent braiding wire is hand-woven on the stent knitting mold, during the weaving process. The brackets are placed on both ends of the bracket; the braided bracket is heat-treated and shaped together with the mold, and the bracket is removed from the mold after thermoforming, and the bracket and the bracket indicator are welded together; B. the stent is conveyed by a guide wire, Extruding the plastic pipe on the pipe extruder, fusing the plastic pipe after the plastic pipe is assembled, and injecting the joint on the injection molding machine after the pipe is completed; C. Weaving the net body of the plugging device, weaving the plugging device The wire is woven on the knitting machine to evenly distribute the braiding wire of the plugging device; D. The plugging device is fabricated, the net body of the plugging device is mounted on the forming device of the plugging device, and then the mesh body of the plugging device after the molding is heat-treated and shaped After thermoforming, the mold is taken out from the net body of the plugging device, and the distal end of the netting body of the plugging device is equipped with a distal indicator of the blocking device and a proximal end of the blocking device. The connecting device is installed in the proximal end of the blocking device, and the netting device of the blocking device and the distal end of the blocking device and the proximal end of the blocking device are welded by welding, and the meshing device of the sealing device after welding is blocked. Flow film; E. Closing device conveying guide wire shaft manufacturing: The alloy wire is placed on a stainless steel ruler for a good length, the alloy wire is cut with a diagonal pliers, and one end of the middle shaft is ground on a cylindrical grinding machine. , the plug head and the blocking device conveying guide wire are connected by welding.
14、根据权利要求 13所述的主动脉瘤夹层支架系统的制备方法, 其特征在于所述热处理 采用真空热处理炉, 在 50CTC的条件下保温 30分钟; 所述焊接采用激光焊接机或 TIG焊接方 式焊接。  The method for preparing an aortic aneurysm stent system according to claim 13, wherein the heat treatment is performed by a vacuum heat treatment furnace under the condition of 50 CTC for 30 minutes; and the welding is performed by a laser welding machine or a TIG welding method. welding.
PCT/CN2012/077245 2011-08-03 2012-06-20 Aortic aneurysm dissection stent system and preparation method thereof WO2013016984A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201110221019.5A CN102379731B (en) 2011-08-03 2011-08-03 Aortic aneurysm dissection stent system and preparation method thereof
CN201110221019.5 2011-08-03

Publications (1)

Publication Number Publication Date
WO2013016984A1 true WO2013016984A1 (en) 2013-02-07

Family

ID=45819850

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2012/077245 WO2013016984A1 (en) 2011-08-03 2012-06-20 Aortic aneurysm dissection stent system and preparation method thereof

Country Status (2)

Country Link
CN (1) CN102379731B (en)
WO (1) WO2013016984A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10888414B2 (en) 2019-03-20 2021-01-12 inQB8 Medical Technologies, LLC Aortic dissection implant

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102379731B (en) * 2011-08-03 2014-02-19 北京华医圣杰科技有限公司 Aortic aneurysm dissection stent system and preparation method thereof
CN102784019B (en) * 2012-08-07 2014-12-03 湖南瑞康通科技发展有限公司 Cerebral aneurysm scaffold system and preparation method thereof
AU2013336672B2 (en) * 2012-10-25 2017-11-23 Sahajanand Medical Technologies Private Limited Radiopaque marker for bioresorbable stents
EP3679871A1 (en) * 2012-12-26 2020-07-15 Covidien LP Devices for the treatment of vascular defects
CN103252013B (en) * 2013-06-04 2014-10-22 南京大学医学院附属鼓楼医院 Puncturing sheath for aortic vessel lumen interventional surgery
US9713475B2 (en) * 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
CN104287871B (en) * 2014-10-24 2017-03-22 黄连军 Aortic dissection aneurysm covered stent
CN105816215A (en) * 2015-12-10 2016-08-03 北京泰杰伟业科技有限公司 Regional blood flow guiding device as well as preparation method and use method thereof
CN105534551B (en) * 2016-01-12 2018-05-18 青岛市妇女儿童医院 A kind of children's Occluder delivery system for cardiac surgery department
CN105902291A (en) * 2016-04-08 2016-08-31 张小曦 Intracranial aneurysm interventional closure treatment device
CN105943107A (en) * 2016-05-26 2016-09-21 高不郎 A stent for blocking arterial aneurysm of an initial part of an arterial branch and application thereof
CN107744417B (en) * 2017-10-18 2018-12-14 易浦润(上海)生物技术有限公司 One kind can post-operation adhesion preventing instrument in degradable uterine cavity
CN108143447B (en) * 2017-12-26 2021-04-06 许尚栋 Aortic dissection distal end breach plugging device
CN110074829A (en) * 2018-01-25 2019-08-02 杭州唯强医疗科技有限公司 Aorta interlayer crevasse plugging device
CN108125730A (en) * 2018-02-27 2018-06-08 北京裕恒佳科技有限公司 Artificial blood vessel's preformed hole locking device and its conveying device
CN108776961B (en) * 2018-04-02 2022-08-02 东南大学 First-breach position positioning method for thoracic aortic dissection aneurysm
WO2020207484A1 (en) * 2019-04-11 2020-10-15 杭州唯强医疗科技有限公司 Occluder, occluder fastening system and fastening method
CN113017746A (en) * 2019-12-24 2021-06-25 上海微创心脉医疗科技(集团)股份有限公司 Interlayer crevasse plugging system
CN113509234B (en) * 2021-05-10 2023-01-24 杭州德诺脑神经医疗科技有限公司 Delivery system
CN113951965B (en) * 2021-11-18 2023-06-06 河北省胸科医院 A support shutoff umbrella for pleural fistula

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001003607A2 (en) * 1999-07-12 2001-01-18 Scimed Life Systems, Inc. Aneurysm closure device assembly
US20040044391A1 (en) * 2002-08-29 2004-03-04 Stephen Porter Device for closure of a vascular defect and method of treating the same
CN1572261A (en) * 2003-05-23 2005-02-02 太雄医疗器株式会社 Variable state maintaining type implant fixing mould and method of producing the same
CN1736346A (en) * 2004-08-19 2006-02-22 龚善石 Stopper for congenital heart structural defect, its manufacturing method and delivery arrangement
CN2933337Y (en) * 2006-07-26 2007-08-15 维科医疗器械(苏州)有限公司 Arteria covering membrane supporter capable of positioning release accurately and its conveyor
CN101180006A (en) * 2005-05-25 2008-05-14 切斯纳特医药技术公司 System and method for delivering and deploying and occluding device within a vessel
CN201098220Y (en) * 2007-04-12 2008-08-13 先健科技(深圳)有限公司 Plugging device capable of reducing thrombus source
CN102379731A (en) * 2011-08-03 2012-03-21 北京华医圣杰科技有限公司 Aortic aneurysm dissection stent system and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3048277C (en) * 2008-05-02 2022-06-21 Sequent Medical Inc. Filamentary devices for treatment of vascular defects
CN101675904A (en) * 2008-09-19 2010-03-24 景在平 Self-protuberant aortic intracavity implant
CN101606869A (en) * 2009-07-13 2009-12-23 成正辉 Cerebral aneurysm endovascular plastic repair bracket and conveyer device thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001003607A2 (en) * 1999-07-12 2001-01-18 Scimed Life Systems, Inc. Aneurysm closure device assembly
US20040044391A1 (en) * 2002-08-29 2004-03-04 Stephen Porter Device for closure of a vascular defect and method of treating the same
CN1572261A (en) * 2003-05-23 2005-02-02 太雄医疗器株式会社 Variable state maintaining type implant fixing mould and method of producing the same
CN1736346A (en) * 2004-08-19 2006-02-22 龚善石 Stopper for congenital heart structural defect, its manufacturing method and delivery arrangement
CN101180006A (en) * 2005-05-25 2008-05-14 切斯纳特医药技术公司 System and method for delivering and deploying and occluding device within a vessel
CN2933337Y (en) * 2006-07-26 2007-08-15 维科医疗器械(苏州)有限公司 Arteria covering membrane supporter capable of positioning release accurately and its conveyor
CN201098220Y (en) * 2007-04-12 2008-08-13 先健科技(深圳)有限公司 Plugging device capable of reducing thrombus source
CN102379731A (en) * 2011-08-03 2012-03-21 北京华医圣杰科技有限公司 Aortic aneurysm dissection stent system and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10888414B2 (en) 2019-03-20 2021-01-12 inQB8 Medical Technologies, LLC Aortic dissection implant

Also Published As

Publication number Publication date
CN102379731B (en) 2014-02-19
CN102379731A (en) 2012-03-21

Similar Documents

Publication Publication Date Title
WO2013016984A1 (en) Aortic aneurysm dissection stent system and preparation method thereof
US11547418B2 (en) Embolic implant and method of use
US10517712B2 (en) Bifurcated medical device for treating a target site and associated method
EP2777638B1 (en) Stent delivery apparatus
JP5619703B2 (en) Endoprosthesis deployment system for treating vascular bifurcations
US9402634B2 (en) Device and method for treating vascular abnormalities
EP3501426B1 (en) Blockstent device
AU2009288489B2 (en) Stent graft having extended landing area and method for using the same
CN108186176B (en) Implant delivery system
JP2008173460A (en) System for controlled delivery of stent and graft
KR20140019286A (en) Implant for influencing the blood flow in arteriovenous malformations
JP2011041833A (en) Endoprosthesis deployment system which treats vessel branch part
CN107496009A (en) Vascular plaque cutter device
BRPI0611054A2 (en) system for controlled release of stents and grafts
JP2003038657A (en) Intraluminal stent for attaching graft
JP2019502521A (en) Decomposable occluder
CN109248012A (en) The transportation system of implantation material
JP2004506479A (en) Manufacturing method of custom vascular interior device
CN214967138U (en) Ascending aorta covered stent and conveying system assembly
CN106176002A (en) Self-expansion type support
WO2022007282A1 (en) Axially compressible and stretchable bare stent
US20140249617A1 (en) Balloon Expandable Stent Graft and Apparatus and Method for Expanding a Balloon Expandable Stent Graft
JPWO2020039653A1 (en) Medical tubular body transport device
CN211460699U (en) Delivery guide wire and treatment device
CN117045302A (en) Conveyor and spoiler conveying system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12820455

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12820455

Country of ref document: EP

Kind code of ref document: A1